✦ LIBER ✦

Epidemiological situation and treatment of patients with thalassemia major in Germany: results of the German multicenter β-thalassemia study

✍ Scribed by H. Cario; K. Stahnke; S. Sander; E. Kohne

Publisher: Springer
Year: 2000
Tongue: English
Weight: 311 KB
Volume: 79
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s002770050002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Growth hormone (GH) deficiency in patien

Growth hormone (GH) deficiency in patients with β-thalassemia major and the efficacy of recombinant GH treatment

✍ K.H. Wu; F.J. Tsai; C.T. Peng 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 127 KB

The influence of treatment in specialize

The influence of treatment in specialized centers on survival of patients with thalassemia major

✍ Gian Luca Forni; Matteo Puntoni; Elio Boeri; Laura Terenzani; Manuela Balocco 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB 👁 2 views

Major reduction in spinal inflammation i

Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab: Results of a multicenter, randomized, double-blind, placebo-controlled magnetic resonance imaging study

✍ Jürgen Braun; Robert Landewé; Kay-Geert A. Hermann; John Han; Songkai Yan; Paul 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 227 KB 👁 2 views

## Abstract ## Objective To determine whether the effects of anti–tumor necrosis factor α (TNFα) in reducing the signs and symptoms of ankylosing spondylitis (AS) coincide with a reduction in spinal inflammation as detected by magnetic resonance imaging (MRI). ## Methods Pre‐ and postgadolinium

Topotecan and carboplatin in patients wi

Topotecan and carboplatin in patients with platinum-sensitive recurrent ovarian cancer. Results of a multicenter NOGGO: phase I/II study

✍ Dominique Koensgen; Dirk Stengel; Antje Belau; Peter Klare; Guelten Oskay-Oezcel 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 324 KB

Treatment of Bendamustine and Prednisone

Treatment of Bendamustine and Prednisone in patients with newly diagnosed multiple myeloma results in superior complete response rate, prolonged time to treatment failure and improved quality of life compared to treatment with Melphalan and Prednisone—a randomized phase III study of the East German Study Group of Hematology and Oncology (OSHO)

✍ W. Pönisch; P. S. Mitrou; K. Merkle; M. Herold; M. Assmann; G. Wilhelm; K. Dachs 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 344 KB

Equitoxicity of bolus and infusional eto

Equitoxicity of bolus and infusional etoposide: results of a multicenter randomised trial of the German High-Grade Non-Hodgkins Lymphoma Study Group (DSHNHL) in elderly patients with refractory or relapsing aggressive non-Hodgkin lymphoma using the CEMP regimen (cisplatinum, etoposide, mitoxantrone and prednisone)

✍ Carsten Zwick; Josef Birkmann; Norma Peter; Heinrich Bodenstein; Roland Fuchs; M 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 259 KB